Drugs like aspirin and clopidogrel (Plavix, NYSE:BMY) prevent platelets from clumping together into a clot.
Gate Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals have gained FDA approval for 300 milligram (mg) clopidogrel.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Patients can be tested for these genetic factors to ensure that clopidogrel is the right choice for them.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Clopidogrel is dispensed with a patient Medication Guide that provides important instructions on its use and drug safety information.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Clopidogrel may cause bleeding, which can be serious and sometimes lead to death.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Information about the availability of generic clopidogrel can be obtained from the manufacturers.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Apotex Corporation, Aurobindo Pharma, Mylan Pharmaceuticals, Roxane Laboratories, Sun Pharma, Teva Pharmaceuticals, and Torrent Pharmaceuticals have received approval for 75 mg clopidogrel.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Clopidogrel is FDA-approved to treat patients who have had a recent heart attack or a recent stroke, or have partial or total blockage of an artery (peripheral artery disease).
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Also, certain medicines, such as proton pump inhibitors Prilosec (omeprazole) and Nexium (esomeprazole), reduce the effect of clopidogrel, leaving a person at greater risk for heart attack and stroke.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
Clopidogrel has a boxed warning to alert health care professionals and patients that the drug may not work well for those with certain genetic factors that affect how the body metabolizes the drug.
FORBES: FDA Approves Generic Clopidogrels As Plavix Loses Patent Protection
应用推荐